Status:
UNKNOWN
Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device
Lead Sponsor:
Samsung Medical Center
Conditions:
Sleep Disorder
Breast Cancer
Eligibility:
FEMALE
18-45 years
Brief Summary
The aim of this study is to observe the sleep and activity patterns of pre-menopausal breast cancer patients taking tamoxifen using a wrist-worn internet of things device and questionnaires.
Detailed Description
Breast cancer is the most common malignant tumors occurring in women worldwide. Treatments include surgery, radiation therapy, chemotherapy, hormone therapy, and target therapy. As multidisciplinary t...
Eligibility Criteria
Inclusion
- diagnosed of unilateral breast cancer (stage 0 \~III)
- underwent proper cancer treatment including surgery, chemotherapy, radiation therapy
- age : 18 \~ 45
- scheduled for applying tamoxifen and goserelin
Exclusion
- need CPAP device during sleep due to sleep apnea
- under medication for restless leg syndrome
- previous history of tamoxifen
- irregular bedtime due to shift work
- diagnosed of recurrent or metastatic cancer
- have difficulty understanding and conducting surveys and verbal instructions due to severe cognitive, communication and perception problems
- refuse to participate
- has musculoskeletal system and neurological damage and lesions
Key Trial Info
Start Date :
August 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04116827
Start Date
August 10 2018
End Date
December 31 2020
Last Update
October 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea